Preparation and in- vitro Evaluation of Bioadhesive Vaginal Film of Tinidazole
DOI:
https://doi.org/10.31351/vol33iss3pp150-160Keywords:
Tinidazole, Bioadhesive vaginal films, Hydroxypropyl methylcellulose (HPMC), Polyvinyl pyrrolidone (PVP), Polyvinyl alcohol (PVA)Abstract
Bioadhesive vaginal film is becoming a more effective and convenient dosage form compared to suppositories and gel for vaginal application as a method for the treatment of vaginal infections. This study aimed to prepare and characterize bioadhesive films of tinidazole to be used for vaginal delivery over a prolonged period to treat local infections.
Fourteen formulas of tinidazole films were prepared by solvent evaporation method. Each film was composed of 10 mg tinidazole with different ratios and concentrations of a polymeric combination of polyvinyl alcohol/ polyvinyl pyrrolidone (PVA/PVP) or polyvinyl alcohol/ hydroxypropyl methylcellulose (PVA/HPMC) for formulas A1-A7 and B1-B7, respectively. The prepared films were evaluated for their physicochemical characteristics, content uniformity, swelling, mucoadhesive strength, mucoadhesive time, and drug release. All the prepared films were transparent, had a uniform thickness (0.1-0.15 mm), and exhibited sufficient flexibility with drug content uniformity. The mucoadhesive strength of films was in the range of 28 ± 0.2 to 75 ± 0.01 g. Films containing PVA/HPMC showed higher swelling and lower mucoadhesive strength than those containing PVA/PVP polymeric combination. The in vitro drug release study showed no significant differences (p > 0.05) among films containing PVA/PVP or PVA/HPMC polymeric combinations.
Formulas A3 and B4 were considered as the optimal bioadhesive films containing 3% of PVA: PVP (4:1) and 4% of PVA: HPMC (2:1), respectively as they showed complete flexibility, acceptable mucoadhesive strength and time (43 ± 0.1, 45 ± 0.23 g and 30 ± 0.02, 34 ± 0.01 min, respectively) and prolonged drug release rate.
In conclusion, films of formulas A3 and B4 possess the potential as a delivery system for tinidazole for the treatment of vaginal infections at the site of application.
Received 2/7/2023
Accepted 28/9/2023
Published 15/9/2024
References
Mashburn J. Vaginal infections update. Journal of midwifery & women's health. 2012;57(6):629-34.
Nardis C, Mosca L, Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann Ig. 2013;25(5):443-56.
Azzam WM, Cermeño -Vivas JR, Orellan García Y, Penna SJ. Vulvovaginitis caused by Candida spp. and Trichomonas vaginalis in sexually active women. Invest Clin. 2002;43(1):3–13.
Villagrana‐Zesati R, Reyna‐Figueroa J, Ortiz‐Ibarra J. Short‐term therapy for mixed vaginal infections. International Journal of Gynecology & Obstetrics. 2006;92(2):149-50.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62(4):e1–50.
Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: What we have and what we miss. Expert Opin Pharmacother. 2014;15(5):645–57.
dos Santos AM, Carvalho SG, Araujo VHS, Carvalho GC, Gremião MPD, Chorilli M. Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections. Int J Pharm. 2020; 590:119867.
Baloglu E, Bernkop-Schnürch A, Karavana SY, Senyigit ZA. Strategies to prolong the intravaginal residence time of drug delivery systems. J Pharm Pharm Sci. 2009;12(3):312–36.
Pandey M, Choudhury H, Abdul-Aziz A, Bhattamisra SK, Gorain B, Carine T, et al. Promising drug delivery approaches to treat microbial infections in the vagina: A recent update. Polymers. 2021;23(1):1–65.
Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral Res. 2010;88:S19–29.
Notario-Pérez F, Cazorla-Luna R, Martín-Illana A, Galante J, Ruiz-Caro R, das Neves J, et al. Design, fabrication and characterisation of drug-loaded vaginal films: State-of-the-art. J Control Release. 2020;327:477–99.
Gu J, Yang S, Ho EA. Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells. Mol Pharm. 2015;12(8):2889–903.
Notario-Pérez F, Galante J, Martín-Illana A, Cazorla-Luna R, Sarmento B, Ruiz-Caro R, et al. Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis. Acta Biomater. 2021;121:316–27.
Osmałek T, Froelich A, Jadach B, Tatarek A, Gadziński P, Falana A, Gralińska K, Ekert M, Puri V, Wrotyńska-Barczyńska J, Michniak-Kohn B. Recent advances in polymer-based vaginal drug delivery systems. Pharmaceutics 2021;13(6):884.
Cautela MP, Moshe H, Sosnik A, Sarmento B, das Neves J. Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine. Eur J Pharm Biopharm. 2019;138:3–10.
Calvo NL, Tejada G, Svetaz LA, Quiroga AD, Alvarez VA, Lamas MC, et al. Development and optimization of a new tioconazole vaginal mucoadhesive film using an experimental design strategy. Physicochemical and biological characterization. J Pharm Biomed Anal. 2021;205.
Dolci LS, Albertini B, Di Filippo MF, Bonvicini F, Passerini N, Panzavolta S. Development and in vitro evaluation of mucoadhesive gelatin films for the vaginal delivery of econazole. Int J Pharm. 2020;591:119979.
Madan J, Dagade R, Awasthi R, Dua K. Formulation and solid state characterization of carboxylic acid-based co-crystals of tinidazole: An approach to enhance solubility. Polym Med. 2019;48(2):99–104.
Patnala SRCM, Khagga M, Bhavani R, Bhavani V. Novel salt of Tinidazole with improved solubility and antibacterial activity. Orient J Chem. 2017;33(1):490–9.
Armstrong NR, Wilson JD. Tinidazole in the treatment of bacterial vaginosis. International journal of women's health. 2010:59-65.
Abbaspoor Z, Rabee Z, Najjar S. Efficacy and safety of oral tinidazole and metronidazole in treatment of bacterial vaginosis: a randomized control trial. Int J Pharm Res 2014;4(2):78-83.
Fernando HV, Chan LL, Dang N, Santhanes D, Banneheke H, Nalliah S, et al. Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis. Pharm Dev Technol. 2019;24(3):348–56.
Salih ZT. In vitro Evaluation of Tinidazole Bioadhesive Vaginal Gels. Iraqi J Pharm Sci 2010; 19(2):64-69.
Hiba SM. Investigation the effect of different concentrations of carbomer & Co solvent propylene glycol on the releasing process of tinidazole from vaginal aqueous gel. AJPS. 2006;3(1):75-85.
Mishra R, Joshi P, Mehta T. Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis. Int J Pharm Investig. 2016;6(1):47-55.
Abilova GK, Kaldybekov DB, Irmukhametova GS, Kazybayeva DS, Iskakbayeva ZA, Kudaibergenov SE, et al. Chitosan/poly(2-ethyl-2-oxazoline) films with ciprofloxacin for application in vaginal drug delivery. Materials. 2020;13(7): 1709
Yoo J-W, Acharya G, Lee CH. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide. Biomaterials. 2009;30(23–24):3978–85.
Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Bedoya LM, Peña J, et al. Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV. Int J Pharm. 2019; 570:118643.
Shaikh A, Yeole PG, Iyer D. Formulation and evaluation of stable solid dispersion of anti-protozoal drug. Res. J Pharm Biol Chem Sci. 2013; 4:1495-509.
Mishra R, Soni K, Mehta T. Mucoadhesive vaginal film of fluconazole using cross-linked chitosan and pectin. J Therm Anal Calorim. 2017;130 (3):1683–95.
Pendekal MS, Tegginamat PK. Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine. Acta Pharmaceutica Sinica B. 2012;2(3):318-24.
Gurumurthy V, Deveswaran R, Bharath S, Basavaraj B V, Madhavan V. Development of bioadhesive controlled release ketoconazole vaginal films. Res J Pharm Technol. 2012;5(3):376–82.
Real DA, Martinez M V, Frattini A, Soazo M, Luque AG, Biasoli MS, et al. Design, characterization, and in vitro evaluation of antifungal polymeric films. AAPS PharmSciTech. 2013;14(1):64–73.
Valamla B, Thakor P, Phuse R, Dalvi M, Kharat P, Kumar A, Panwar D, Singh SB, Giorgia P, Mehra NK. Engineering drug delivery systems to overcome the vaginal mucosal barrier: Current understanding and research agenda of mucoadhesive formulations of vaginal delivery. J Drug Deliv Sci Technol. 2022;70:103162.
Abdelrazek EM, Elashmawi IS, Labeeb SJ. Chitosan filler effects on the experimental characterization, spectroscopic investigation and thermal studies of PVA/PVP blend films. Physica B: Condensed Matter. 2010;405(8):2021-7.
Soud SA, Hasoon BA, Abdulwahab AI, Hussein NN, Maeh RK. Synthesis and characterization of plant extracts loaded PVA/PVP blend films and evaluate their biological activities. EurAsian Journal of BioSciences. 2020;14(2):2921-31.
Seabra AB, De Oliveira MG. Poly (vinyl alcohol) and poly (vinyl pyrrolidone) blended films for local nitric oxide release. Biomaterials 2004;25(17):3773-82.
Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, et al. Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004;99(1):73-82.
Patel VM, Prajapati BG, Patel MM. Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride. Acta pharmaceutica. 2007;57(1):61-72.
Thomas J, Lowman A, Marcolongo M. Novel associated hydrogels for nucleus pulposus replacement. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials. 2003;67(4):1329-37.
Pudžiuvelytė L, Drulytė E, Bernatonienė J. Nitrocellulose Based Film-Forming Gels with Cinnamon Essential Oil for Covering Surface Wounds. Polymers. 2023;15(4):1057.
Karavas E, Georgarakis E, Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm. 2006;64(1):115-26.
Bassi P, Kaur G. Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. Eur J Pharm Biopharm. 2015;96:173–84.
Eouani C, Piccerelle P, Prinderre P, Bourret E, et al. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm. 2001;52(1):45-55.
Dobaria NB, Badhan AC, Mashru RC. A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization. AAPS PharmSciTech. 2009;10 (3):951-59
El Sharawy AM, Shukr MH, Elshafeey AH. Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation. Drug delivery. 2017;24(1):1762-9.
Jin SG, Yousaf AM, Kim KS, Kim DW, Kim DS, Kim JK, Yong CS, Youn YS, Kim JO, Choi HG Influence of hydrophilic polymers on functional properties and wound healing efficacy of hydrocolloid based wound dressings. Int J Pharmaceutics. 2016;501(1-2):160-6.
Koland M, Charyulu RN, Vijayanarayana K, Prabhu P. In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride. Int J Pharma Investig. 2011;1(3):164-71
Jain SK, Jain A, Gupta Y, Kharya A. Design and development of a mucoadhesive buccal film bearing progesterone. Pharmazie. 2008;63(2):129-35.
Yamsani VV, Gannu R, Kolli C, Rao MEB, Yamsani MR. Development and in vitro evaluation of buccoadhesive Carvedilol tablets. Acta Pharm. 2007;57(2):185–97.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
